ArticleThe journal of allergy and clinical immunology. Global2026
Outcomes of the Navajo Community Asthma Program during the COVID-19 pandemic.
Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite elevated rates of asthma among Native American children, few interventions have been tested on tribal lands. Objective: Our aim was to test whether the Community Asthma Program reduced the number of asthma exacerbations on the Navajo Nation. Methods: Following 1 year of community engagement meetings on the 27,000-square mile Navajo Nation, a 7-year, stepped wedge study was commenced sequentially in 3 communities, each with its own Indian Health Service medical center and school system. Health care staff were trained in evidence-based guidelines for the management of childhood asthma. School staff were trained in the American Lung Association Asthma 101 and Open Airways for Schools programs. Stock inhaler programs were implemented in schools. The primary outcome, asthma exacerbations, was defined as emergency room visits, hospitalizations, or oral corticosteroid requirement. With the arrival of the coronavirus disease 2019 (COVID-19) pandemic in the second year of the program, schools and medical clinics were closed. All medical visits were conducted through emergency departments. Training in the third community was delayed by 1 year. Results: A total of 439 health care and school staff were trained either in person or virtually. Reflecting national trends, the numbers of asthma exacerbations fell dramatically during the pandemic. After control for the effect of the pandemic, asthma exacerbation visits increased by 53% and routine visits increased by 56%. Conclusions: Although the impacts of the pandemic and the program on asthma exacerbations are difficult to disentangle, the collective evidence indicates that that the program led to increased community awareness of asthma and increased asthma care-seeking behavior by families of children with asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.